# Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer

> **NCT00720083** · PHASE2 · TERMINATED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 34 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** vandetanib
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00720083
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Withdrawal of drug supply.
- **Last updated:** 2015-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720083, "Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00720083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*